These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7851872)

  • 1. Circulating insulin-like growth factor I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss.
    Poulos JE; Leggett-Frazier N; Khazanie P; Long S; Sportsman R; MacDonald K; Caro JF
    Horm Metab Res; 1994 Oct; 26(10):478-80. PubMed ID: 7851872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J; Keliner K; Zilkens T; Schmidt-Gayk H; Selisko T; Scholz GH
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is type II diabetes mellitus (NIDDM) a surgical disease?
    Pories WJ; MacDonald KG; Flickinger EG; Dohm GL; Sinha MK; Barakat HA; May HJ; Khazanie P; Swanson MS; Morgan E
    Ann Surg; 1992 Jun; 215(6):633-42; discussion 643. PubMed ID: 1632685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.
    Tan K; Baxter RC
    J Clin Endocrinol Metab; 1986 Sep; 63(3):651-5. PubMed ID: 3734035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I in non-insulin-dependent diabetic monkeys: basal plasma concentrations and metabolic effects of exogenously administered biosynthetic hormone.
    Bodkin NL; Sportsman R; DiMarchi RD; Hansen BC
    Metabolism; 1991 Nov; 40(11):1131-7. PubMed ID: 1943741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C; Duron F; Binoux M
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K; Cunningham GR; Comstock JP
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
    Kudolo GB; Bressler P; DeFronzo RA
    J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes.
    Jeyaratnaganthan N; Højlund K; Kroustrup JP; Larsen JF; Bjerre M; Levin K; Beck-Nielsen H; Frago S; Hassan AB; Flyvbjerg A; Frystyk J
    Growth Horm IGF Res; 2010 Jun; 20(3):185-91. PubMed ID: 20110184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin, IGF-I,IGF-II and growth hormone, and left ventricular mass in noninsulin-dependent mellitus.
    Rabkin SW; Dawson KG; Bhaumick B; O'Brein E; Kendler DL
    Can J Cardiol; 1996 Mar; 12(3):264-70. PubMed ID: 8624976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass.
    Carbajo MA; Jiménez JM; Castro MJ; Ortiz-Solórzano J; Arango A
    Nutr Hosp; 2014 Nov; 30(5):1032-8. PubMed ID: 25365005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients.
    Bruno G; Gruden G; Barutta F; Cavallo Perin P; Morino M; Toppino M
    Surg Obes Relat Dis; 2015; 11(5):1014-9. PubMed ID: 25979204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.